
Priyanka’s practice encompasses advising entities across the health care and life sciences sectors on complex transactions. Her clients include life sciences companies, pharmaceutical manufacturers, health care providers, payors, health insurers, laboratories, clinical-stage companies, diagnostic companies, and pharmacy benefit managers.
Priyanka’s matters include mergers and acquisitions, technology transactions, capital markets transactions, corporate governance matters, and financing matters. She has experience drafting, negotiating and reviewing transaction documents, collaborating with specialist groups, and managing due diligence reviews. She also regularly drafts agreements for licenses, partnerships, joint ventures, manufacturing arrangements, pharmacy benefit managers, and strategic collaborations involving clinical-stage companies.
Before joining Mintz, Priyanka was an associate in the Corporate and Healthcare/FDA practice areas of a global law firm.
In law school, Priyanka served as chief articles editor for UCLA Law’s Asian & Pacific American Law Journal and president of the Health Law Society. Priyanka earned her BA from the University of California, Berkeley.
viewpoints
PBM Policy and Legislative Update — Winter 2025
February 10, 2025 | Blog | By Theresa Carnegie, Tara E. Dwyer, Rachel A. Alexander, Lauren Moldawer, Bridgette Keller, Priyanka Amirneni, Madison Castle, David Gilboa, Xavier Hardy, Samantha Hawkins, Stephnie John, Alison H. Peters, Pamela Polevoy, Abdie Santiago, Hassan Shaikh, Sophia Temis
The PBM Policy and Legislative Update — Winter 2025 edition builds upon prior PBM Policy and Legislative Updates and summarizes activity from October through December (2024) that affects the PBM industry. It highlights (i) federal activities, (ii) state activities, and (iii) other noteworthy events and trends affecting the PBM industry.
Massachusetts Aligns with National Trends and Enacts Sweeping Legislation to Regulate Pharmaceutical Benefit Managers
January 24, 2025 | Blog | By Theresa Carnegie, Bridgette Keller, David Gilboa, Priyanka Amirneni
On the heels of a nationwide push to regulate pharmacy benefit managers (PBMs), Massachusetts enacted a landmark piece of legislation to increase transparency and oversight within the pharmaceutical supply chain, specifically targeting PBMs. Signed into law by Governor Healey on January 9, 2025, the comprehensive bill, titled “An Act Relative to Pharmaceutical Access, Costs and Transparency” (the Act), introduces a multifaceted approach that aims to reduce prescription drug costs, enhance data transparency, and impose stronger oversight of PBMs and pharmaceutical manufacturers.
podcasts
Health Law Diagnosed – New Year's Gratitude
February 3, 2025 | Podcast | By Bridgette Keller, Alison H. Peters, Samantha Kingsbury, Theresa Carnegie, Joanne Hawana, Abdie Santiago, Stephnie John, Pamela Polevoy, Karen Lovitch, Jean D. Mancheno, Deborah Daccord, Rachel A. Alexander, Jane Haviland, David Gilboa, Kathryn Edgerton, Hassan Shaikh, Madison Castle, Laurence Freedman, Priyanka Amirneni, Samantha Hawkins, Tara E. Dwyer, Rachel Yount, Sophia Temis, Xavier Hardy
Host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon.